Literature DB >> 11323239

Whole-body kinetics and dosimetry of cis-4-[(18)F]fluoro-L-proline.

A R Börner1, K J Langen, H Herzog, K Hamacher, V Müller-Mattheis, T Schmitz, R Ackermann, H H Coenen.   

Abstract

The whole-body distribution of 4-cis[(18)F]fluoro-L-proline (cis-FPro) was studied in six patients with urological tumors by PET. Based on the IMEDOSE and MIRDOSE procedures radiation absorbed doses were estimated from whole-body PET scans acquired at 1 and 3-5 h after i.v. injection of 400 MBq cis-FPro. Cis-FPro showed high retention in the renal cortex and a slight uptake in liver and pancreas. Urinary excretion ranged from 12 to 19% at 5 h p.i. Highest absorbed doses were found for the urinary bladder wall and the kidneys (44.1/44.0 microGy/mbq). The effective dose according to ICRP 60 was 15.1 microSv/mbq for adults. This leads to an effective dose of 6.0 mSv in a PET study using 400 MBq cis-FPro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11323239     DOI: 10.1016/s0969-8051(00)00198-0

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  2 in total

1.  4-Fluoroprolines: Conformational Analysis and Effects on the Stability and Folding of Peptides and Proteins.

Authors:  Robert W Newberry; Ronald T Raines
Journal:  Top Heterocycl Chem       Date:  2016-01-12

2.  cis-4-[18F]fluoro-L-proline Molecular Imaging Experimental Liver Fibrosis.

Authors:  Qi Cao; Xin Lu; Babak Behnam Azad; Martin Pomper; Mark Smith; Jiang He; Liya Pi; Bin Ren; Zhekang Ying; Babak Saboury Sichani; Michael Morris; Vasken Dilsizian
Journal:  Front Mol Biosci       Date:  2020-05-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.